SubscribeElsewhere on HealthThreads: Prostate cancer | Weight loss | Erectile dysfunction | Asthma | Cholesterol | Heart disease | Rheumatoid arthritis | Pancreatic cancer | Sleep apnea |
# 7 News Source
Yahoo! Finance
Yahoo! Finance (biz.yahoo.com) has great Diabetes news, photos, videos and more
Tuesday, Jan 26
Lexicon to Host Conference Call and Webcast to Review Top-Line Phase 2 Results From Diabetes Trial
Lexicon Pharmaceuticals, Inc. will hold a conference call on Thursday, January 28, 2010 at 11:30 am Eastern Time to discuss its recent top-line Phase 2 clinical results with LX4211, Lexicon's once-per-day, orally-delivered, small molecule drug candidate for the treatment of type 2 d...
Thursday, Jan 21
MDRNA, Inc. Announces Allowance of European Patent Covering Formulations for Rapid Acting Insulin
BOTHELL, WA--(Marketwire - 01/21/10) - MDRNA, Inc. (NASDAQ: MRNA - News ), a leading RNAi-based drug discovery and development company, today announced that the European Patent Office intends to grant a patent for application EP06826368 covering formulations for the intranasal del...
Changes in the Position of Conventional Insulin Pumps Shown to Significantly Impact Accuracy of Insulin Delivery
SANTA BARBARA, CA--(Marketwire - 01/21/10) - Researchers at Sansum Diabetes Research Institute and University of California, Santa Barbara have concluded that changing the height of a conventional insulin pump in relation to its tubing and infusion set can significantly impact ex...
Thursday, Jan 7
Nine Achievements in Diabetes in 2009
ALEXANDRIA, VA--(Marketwire - 01/07/10) - In a year that will be remembered for swine flu and health care reform, the American Diabetes Association today released a year-in-review list on another topic that received major headlines in 2009: diabetes. The list, found at diabetes.org , f...
Wednesday, Jan 6
Bristol-Myers Squibb/AstraZeneca's Onglyza Will Garner Peak Year Sales of More Than $1 Billion in the Type 2 Diabetes ...
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of type 2 diabetes, Bristol-Myers Squibb/AstraZeneca's Onglyza will garner peak year blockbuster sales of more than $1 billion in the...
Monday, Jan 4
Insulet and Ypsomed Sign International Distribution Agreement for the OmniPod Insulin Management System
Insulet Corporation , the leader in tubing-free insulin pump technology with its OmniPod® Insulin Management System, and Ypsomed AG , a leading independent diabetes specialist and technology provider of innovative injection systems for self-medication in Europe, today announc...
Thursday, Dec 17
Pico-Tesla Reports First Seven Patients Enrolled in IRB-Approved Pilot Study for Treating Type 2 Diabetes with Its ...
LITTLETON, Colo.----Pico-Tesla, The Magneceutical™ Therapy Company, announced today that it has enrolled the first seven patients for a randomized, double-blind, placebo-controlled Pilot Study of persons who have type 2 diabetes, the most common form of diabetes.
